A 3-year Post-marketing Observational Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece.
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2013
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 10 Jun 2017 Biomarkers information updated
- 13 Aug 2012 Actual end date added as reported by ClinicalTrials.gov record.
- 13 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.